Tag: Opsens

Opsens receives 510(k) clearance for the OptoMonitor II providing extended indication

Opsens has announced 510(k) clearance from the US Food and Drug Administration (FDA) for the OptoMonitor II, a new multimodality monitor designed to combine the...

Pat Mackin appointed as a company director of Opsens

Opsens, which has an advanced optical-based pressure guidewire (OptoWire) that aims at improving the clinical outcome of patients with coronary artery disease, has announced...